Mease Pathology Associates INC
Mease Pathology Associates INC was paid $340K by Medicaid between Jan 2018 and Oct 2022, across 92 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 24% of everything it billed.
33Billing provider infoMEASE PATHOLOGY ASSOCIATES INC
DUNEDIN, FL 34698
DUNEDIN, FL 34698
33aNPI1730240995assigned 12/12/2006
33bProvider typeLegal Medicine
28Total paid$340K
24GClaims114,646
24DCodes billed92
24AFirst – last monthJan 2018 – Oct 2022
Compared with peers
Next to other Legal Medicine providers in Florida
Rank by total paid#1 of 19
Median peer was paid$18K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 991 | $8K | |
| 2019 | 13,195 | $34K | |
| 2020 | 21,678 | $81K | |
| 2021 | 44,727 | $138K | |
| 2022 | 34,055 | $78K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 24% | 16,060 | 13,125 | $82K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 3,111 | 2,884 | $45K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 11% | 2,213 | 2,119 | $37K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 9.4% | 1,821 | 1,208 | $32K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.9% | 1,046 | 936 | $20K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.4% | 3,262 | 2,836 | $18K |
| 80053 | Comprehensive metabolic panel | 4.9% | 9,315 | 7,674 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.8% | 1,066 | 1,044 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 4,683 | 3,718 | $5K |
| 88307 | 1.5% | 173 | 99 | $5K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 1,038 | 988 | $5K |
| 83520 | 1.3% | 1,870 | 1,541 | $5K |
80 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.3% | 934 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 2,518 | $4K |
| 87040 | 1.0% | 2,543 | $3K | |
| 85027 | <1% | 2,921 | $3K | |
| 80074 | <1% | 429 | $3K | |
| 84484 | <1% | 4,170 | $3K | |
| 82805 | <1% | 314 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 103 | $2K |
| 80047 | <1% | 4,784 | $2K | |
| 84703 | <1% | 3,209 | $2K | |
| 87641 | <1% | 431 | $2K | |
| 87480 | <1% | 636 | $1K | |
| 87077 | <1% | 1,378 | $1K | |
| 85380 | <1% | 540 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 867 | $1K |
| 83605 | <1% | 1,863 | $1K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 934 | $1K |
| 81025 | <1% | 1,169 | $1K | |
| 83735 | <1% | 2,727 | $1K | |
| 86850 | <1% | 2,449 | $1K | |
| 87631 | <1% | 182 | $1K | |
| 82948 | <1% | 3,427 | $1K | |
| 87186 | <1% | 1,035 | $1K | |
| 80076 | <1% | 747 | $1K | |
| 83690 | <1% | 2,844 | $1K | |
| 82803 | <1% | 90 | $874.75 | |
| 84702 | <1% | 520 | $844.96 | |
| 86140 | <1% | 1,565 | $825.07 | |
| 80061 | Lipid panel | <1% | 453 | $819.32 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 152 | $809.18 |
| 87660 | <1% | 705 | $695.95 | |
| 87070 | <1% | 587 | $692.29 | |
| 82728 | <1% | 479 | $667.43 | |
| 85730 | <1% | 644 | $664.54 | |
| 87205 | <1% | 972 | $597.02 | |
| 82607 | <1% | 175 | $593.14 | |
| 83880 | <1% | 1,696 | $555.96 | |
| 85014 | <1% | 1,057 | $544.81 | |
| 85610 | <1% | 2,412 | $461.92 | |
| 86900 | <1% | 2,792 | $415.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 428 | $387.49 |
| 86901 | <1% | 2,785 | $326.83 | |
| 87510 | <1% | 614 | $298.28 | |
| 82550 | <1% | 422 | $218.33 | |
| 82746 | <1% | 140 | $213.30 | |
| 84156 | <1% | 541 | $188.98 | |
| 81001 | <1% | 178 | $175.45 | |
| 82570 | <1% | 489 | $165.32 | |
| 86780 | <1% | 521 | $151.55 | |
| 86592 | <1% | 252 | $145.12 | |
| 85652 | <1% | 625 | $144.97 | |
| 88342 | <1% | 33 | $125.15 | |
| 84100 | <1% | 530 | $123.22 | |
| 88304 | <1% | 26 | $114.72 | |
| 80320 | <1% | 57 | $106.98 | |
| 85018 | <1% | 1,097 | $101.04 | |
| 83550 | <1% | 165 | $100.93 | |
| 80202 | <1% | 94 | $100.40 | |
| 82140 | <1% | 17 | $99.29 | |
| 83540 | <1% | 252 | $98.92 | |
| 87075 | <1% | 152 | $92.27 | |
| 86880 | <1% | 180 | $79.49 | |
| 87481 | <1% | 13 | $69.53 | |
| 87209 | <1% | 15 | $53.73 | |
| 84112 | <1% | 39 | $47.19 | |
| 86703 | <1% | 86 | $46.73 | |
| 81003 | <1% | 165 | $40.46 | |
| 83615 | <1% | 173 | $33.72 | |
| 87640 | <1% | 33 | $32.18 | |
| 86308 | <1% | 37 | $22.53 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 18 | $18.72 |
| 85045 | <1% | 46 | $16.43 | |
| 85378 | <1% | 63 | $16.07 | |
| 87177 | <1% | 15 | $14.44 | |
| 82010 | <1% | 52 | $14.25 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 146 | $9.26 |
| 84550 | <1% | 46 | $8.21 | |
| 82272 | <1% | 27 | $7.42 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 883 | $0.00 |
| 0240U | 0% | 80 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, CHRISTOPHER (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Serenity Care Resources LLC | Ridley Park, PA | $3.57M |
| Clear Blue Behavioral Services LLC | Frankfort, KY | $817K |
| Toothtime Family Dentistry PLLC | New Braunfels, TX | $640K |
| Toothtime Family Dentistry San Antonio PLLC | San Antonio, TX | $635K |
| Toothtime Family Dentistry PLLC | Seguin, TX | $110K |
| Ophthalmic Surgical Associates INC | Chester, PA | $39K |
| Williams Eye Works, INC | Staten Island, NY | $21K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.